Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Physician Maxime Dougados, MD, Is Intent on Advancing Clinical Measurement in Rheumatology

Gretchen Henkel  |  Issue: September 2013  |  September 1, 2013

Dr. Dougados is well known for the quality of young talent he has nurtured over the years. He is an avid supporter of EMEUNET [Emerging EULAR Network] (of which Dr. Gossec, along with Daniel Aletaha and Maya Burch, is a co-founder) and has always encouraged his trainees to grow. “There is a famous African saying,” says Dr. Dougados, paraphrasing the translation, “that you recognize the great people as the ones who are able to accept that their collaborators are growing even higher than they are.”

That’s exactly the type of leadership quality that Claire Bombardier, MD, professor of medicine and rheumatology division director at the University of Toronto in Ontario, has observed in her colleague. “Part of his success is his democratic approach,” she says. Dr. Bombardier met Dr. Dougados 25 years ago, when he invited her to speak at a meeting of the French Rheumatology Association. At that time, she notes, clinical epidemiology and clinical research methodology were not that prevalent, but Dr. Dougados had already written his book on measurement. “It was unusual, in those days, for a rheumatologist to write books on methods of research,” Dr. Bombardier says. “Not only did he have the intellectual curiosity, but he had the people skills to rally people around him to do things.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Pisetsky

I was attracted to medicine because of the possibility to have a human relationship in the job. I had in mind never to work alone in an office, but to work in connection with people.

—Maxime Dougados, MD

Raising the Standard

Dr. Dougados has employed his talents for group dynamics in myriad domains, and has been, says Dr. Kvien, “a key person in formalizing the collaboration with ACR on various projects.” Dr. Dougados recalls a seminal conversation in 2006 in San Antonio, Texas, with Sherine Gabriel, MD, MSc, an epidemiologist who trained with Dr. Bombardier in Toronto, and who was his counterpart in clinical affairs with the ACR. (Dr. Gabriel later become president of the ACR.) “That was the beginning of the story of the ACR/EULAR criteria for rheumatoid arthritis, and three years later, the criteria resulted in publication in both journals of our societies.5,6 Can you imagine? Twenty years ago it was impossible to imagine that this would be the result,” he says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Gossec pointed out that he has been a driving force behind the Collège Français des Enseignants en Rhumatologie [COFER], the Consortium of French Professors of Rheumatology. “Dr. Dougados is very critical of keeping patients in the hospital too long or not doing proper workups. He led the group to establish a list of practice standards for rheumatologists.”

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Axial SpondyloarthritisPractice SupportProfiles

Related Articles

    Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances

    May 8, 2012

    Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.

    “A Common Language for Spondyloarthritis”

    December 1, 2010

    ASAS fills a niche, changes dogma with consensus approach

    The Key to Early Rheumatoid Arthritis

    September 1, 2010

    The conundrum of classification versus diagnosis

    Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

    September 11, 2020

    EULAR 2020 e-CONGRESS—In what speakers at the European e-Congress of Rheumatology described as the first treat-to-target and tight control (T2T/TC) strategy trial in axial spondyloarthritis (AxSpA), researchers found such a strategy has both health and financial benefits. In the year-long study—called TICOSPA—centers were randomized to apply either a T2T/TC strategy or care left to the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences